Apr 12, 2023 | Press Releases
TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data Cambridge, MA, April 12, 2023 — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of...
Apr 4, 2023 | Press Releases
As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary. Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development...
Feb 21, 2023 | Press Releases
Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...
Feb 14, 2023 | Press Releases
Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....
Jan 17, 2023 | Press Releases
Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...
Jan 6, 2023 | Blog, Events, Published Research
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...
Dec 15, 2022 | Press Releases
Cambridge, MA, December 15, 2022 — South Tees Hospitals NHS Foundation Trust, one of the most active research organizations in the northeast of England, has joined the TriNetX network to increase its visibility to commercial partners for additional research...
Oct 20, 2022 | Press Releases
Researchers can now run complex data analytics and artificial intelligence/machine learning using TriNetX to unlock new opportunities with remarkable clinical detail Cambridge, MA, October 20, 2022 — TriNetX, the global network of healthcare organizations driving...
Oct 18, 2022 | Press Releases
Cambridge, MA, October 18, 2022 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of OncologyInformationService e.K. (OIS) and its subsidiary...
Sep 9, 2022 | Press Releases
Lyon, France, September 9, 2022 – Centre Léon Bérard (CLB), a Comprehensive Cancer Center in Lyon and Rhône-Alpes has joined the TriNetX global health research network. The TriNetX Network is comprised of healthcare organizations and life sciences companies...
